DOP2011000397A - Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a - Google Patents

Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a

Info

Publication number
DOP2011000397A
DOP2011000397A DO2011000397A DO2011000397A DOP2011000397A DO P2011000397 A DOP2011000397 A DO P2011000397A DO 2011000397 A DO2011000397 A DO 2011000397A DO 2011000397 A DO2011000397 A DO 2011000397A DO P2011000397 A DOP2011000397 A DO P2011000397A
Authority
DO
Dominican Republic
Prior art keywords
phenylimidazol
inhibitors
new derivatives
pde10a
enzyme
Prior art date
Application number
DO2011000397A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Ritzen
Jan Kehler
Morten Langgard
Jacob Nielsen
John Paul Kilburn
Mohamed M Farah
Original Assignee
H Lundbeck & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2009/050134 external-priority patent/WO2009152825A1/en
Application filed by H Lundbeck & Co As filed Critical H Lundbeck & Co As
Publication of DOP2011000397A publication Critical patent/DOP2011000397A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DO2011000397A 2009-06-19 2011-12-19 Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a DOP2011000397A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/050134 WO2009152825A1 (en) 2008-06-20 2009-06-19 Novel phenylimidazole derivatives as pde10a enzyme inhibitors

Publications (1)

Publication Number Publication Date
DOP2011000397A true DOP2011000397A (es) 2012-07-15

Family

ID=42321053

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000397A DOP2011000397A (es) 2009-06-19 2011-12-19 Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a

Country Status (28)

Country Link
EP (1) EP2443105B1 (enExample)
JP (1) JP5768044B2 (enExample)
AR (1) AR077144A1 (enExample)
AU (1) AU2010262190B2 (enExample)
BR (1) BRPI1015983A2 (enExample)
CA (1) CA2765750A1 (enExample)
CR (1) CR20110654A (enExample)
CY (1) CY1115971T1 (enExample)
DK (1) DK2443105T3 (enExample)
DO (1) DOP2011000397A (enExample)
ES (1) ES2527216T3 (enExample)
GE (1) GEP20146100B (enExample)
GT (1) GT201100322A (enExample)
HR (1) HRP20141222T1 (enExample)
IL (1) IL216684A (enExample)
MA (1) MA33367B1 (enExample)
MX (1) MX2011013400A (enExample)
MY (1) MY156785A (enExample)
NZ (1) NZ597203A (enExample)
PL (1) PL2443105T3 (enExample)
PT (1) PT2443105E (enExample)
SG (1) SG176680A1 (enExample)
SI (1) SI2443105T1 (enExample)
SM (1) SMT201500003B (enExample)
TW (1) TW201100430A (enExample)
UA (1) UA106378C2 (enExample)
WO (1) WO2010145668A1 (enExample)
ZA (1) ZA201109271B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
JO3089B1 (ar) * 2010-11-19 2017-03-15 H Lundbeck As مشتقات ايميدازول كمثبطات لانزيمات pde10a
WO2012112946A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
WO2013034758A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Substituted triazolopyrazines and uses thereof
US9056863B2 (en) 2011-09-09 2015-06-16 H. Lundbeck A/S Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof
CN103874701A (zh) * 2011-09-09 2014-06-18 H.隆德贝克有限公司 吡啶化合物和其用途
WO2013034755A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders
TWI570124B (zh) 2011-12-21 2017-02-11 H 朗德貝克公司 作為pde10a酵素抑制劑的喹啉衍生物
WO2013107856A1 (en) * 2012-01-20 2013-07-25 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
WO2013127817A1 (en) 2012-02-27 2013-09-06 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
BR112020013743A2 (pt) * 2018-11-06 2020-12-01 H. Lundbeck A/S hemiadipato de 5,8-dimetil-2-[2-(1-metil-4-fenil-1h-imidazol-2-il)-etil]-[1,2,4]triazolo[1,5-a]pirazina
WO2020094592A1 (en) * 2018-11-06 2020-05-14 H. Lundbeck A/S Compounds for treating negative symptoms and cognitive impairments

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826833A (en) 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
FR2824065A1 (fr) 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
WO2004024705A1 (ja) 2002-09-10 2004-03-25 Takeda Pharmaceutical Company Limited 5員複素環化合物
AU2003288352A1 (en) 2002-10-30 2004-06-07 Centre National De La Recherche Scientifique (Cnrs) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
EP1641457B1 (en) 2003-06-30 2009-08-05 Nycomed GmbH Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
MXPA05013553A (es) 2003-06-30 2006-03-09 Altana Pharma Ag Pirrolodihidroisoquinolinas como inhibidores de pde10.
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
EP1723134A2 (en) 2004-02-18 2006-11-22 Pfizer Products Incorporated Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
FR2870539B1 (fr) 2004-05-19 2006-08-04 Greenpharma Sa Sa Nouvelles methodes et medicaments
BRPI0511854A (pt) 2004-06-07 2008-01-15 Pfizer Prod Inc inibição de fosfodiestearase 10 como tratamento para condições relacionados com a obesidade e relacionadas a sìndrome metabólica
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
CA2578996A1 (en) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
MX2008010668A (es) * 2006-02-21 2008-10-01 Amgen Inc Derivados de cinolina como inhibidores de fosfodiesterasa 10.
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物

Also Published As

Publication number Publication date
CA2765750A1 (en) 2010-12-23
ES2527216T3 (es) 2015-01-21
HRP20141222T1 (hr) 2015-02-27
WO2010145668A1 (en) 2010-12-23
AU2010262190A1 (en) 2012-01-19
SG176680A1 (en) 2012-01-30
AR077144A1 (es) 2011-08-03
MY156785A (en) 2016-03-31
CY1115971T1 (el) 2017-01-25
ZA201109271B (en) 2013-02-27
GT201100322A (es) 2014-02-06
IL216684A (en) 2016-03-31
MA33367B1 (fr) 2012-06-01
JP5768044B2 (ja) 2015-08-26
JP2012530086A (ja) 2012-11-29
SI2443105T1 (sl) 2015-02-27
GEP20146100B (en) 2014-05-27
UA106378C2 (ru) 2014-08-26
PL2443105T3 (pl) 2015-03-31
CR20110654A (es) 2012-03-09
EP2443105A1 (en) 2012-04-25
IL216684A0 (en) 2012-02-29
PT2443105E (pt) 2015-01-14
TW201100430A (en) 2011-01-01
SMT201500003B (it) 2015-03-05
BRPI1015983A2 (pt) 2016-04-19
MX2011013400A (es) 2012-02-21
DK2443105T3 (en) 2015-01-12
EP2443105B1 (en) 2014-10-29
AU2010262190B2 (en) 2013-01-31
HK1171446A1 (en) 2013-03-28
NZ597203A (en) 2013-03-28

Similar Documents

Publication Publication Date Title
PT2513105E (pt) Derivados de 2-arilimidazole como inibidores da enzima pde10a
BR112013013914A2 (pt) derivados de hidantoína úteis como inibidores de kv3
BRPI1015238A2 (pt) diamidas de azetidilina como inibidores de monoaciglicerol lipase
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
EP2480576A4 (en) PCSK9 ANTAGONISTS
BRPI0913879A2 (pt) fenilpirazinonas como inibidores de quinase
BRPI0920135A2 (pt) imidazopiridazinacarbonitrilos úteis como inibidores de quinase
DOP2012000282A (es) Indoles sustituidos como inhibidores ezh2
EP2456440A4 (en) Quinolinone PDE2 INHIBITORS
CR20130192A (es) Derivados de bencimidazol como inhibidores de cinasa p13
BRPI0913580A2 (pt) pirrolopiridinas como inibidores de quinase
EP2641343A4 (en) CONFIGURATION OF A BUILDING
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
PL2443105T3 (pl) Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A
BRPI1008744A2 (pt) hidrotratamento de caboidratos
EP2467382A4 (en) AMINO-TETRA HYDRO-pyridopyrimidine PDE10 INHIBITORS
DK2513106T3 (da) Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
BR112013012378A2 (pt) derivados de imidazol como inibidores de enzima pde10a
EP2413941A4 (en) Renin Inhibitors
CO6900148A2 (es) Inhibidores de la enzima activadora de nedd8
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
EP2435048A4 (en) RADIOACTIVELY MARKED PDE10 HEMMER
PT2492266E (pt) Derivado de 5-hidroxipirimidino-4-carboxamida
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT